Clinical impact of plasma cell-free DNA metagenomic next-generation sequencing testing in neonatal and infant populations.

Published 07/06/2026

Research record: Clinical impact of plasma cell-free DNA metagenomic next-generation sequencing testing in neonatal and infant populations.

Published in Antimicrob Steward Healthc Epidemiol; first publication date 2026-07-06. PMID 42422873.

This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-07-06

Updated

2026-10-20

Disclaimer

professional use

References